Diabetes technology: A primer highlighting the role of the pharmacist

Rick Hess, Christie Schumacher, Heather P. Whitley, Sara Reece, Emily L. Knezevich, Lea E. DeLa Peña, Benjamin Gross, Jon T. Knezevich, Regina Ginzburg, Nicole P. Albanese, Diana Isaacs

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

The rapid advancement of technology has ushered in a new era of diabetes management, especially with regard to continuous glucose monitoring (CGM) and insulin delivery systems. Technology is changing at a fast pace and these tools can be unknown or confusing to people with diabetes. Pharmacists can play a major role in reducing barriers and facilitating shared decision-making regarding the individualization of technology in diabetes care. The Endocrine and Metabolism PRN Research Committee solicited the PRN membership to draft an opinion paper on diabetes technology using the Identify-Configure-Collaborate (ICC) framework from the Association of Diabetes Care and Education Specialists. The primary goal of the opinion paper is to provide an educational primer to health care professionals interested in learning more about the emerging diabetes technology landscape and highlight the role of the pharmacist within the ICC framework.

Original languageEnglish
Pages (from-to)1307-1323
Number of pages17
JournalJACCP Journal of the American College of Clinical Pharmacy
Volume5
Issue number12
DOIs
StatePublished - Dec 2022
Externally publishedYes

Keywords

  • continuous glucose monitors
  • continuous subcutaneous insulin infusion
  • diabetes technology
  • pharmacist
  • type 1 diabetes
  • type 2 diabetes

Fingerprint

Dive into the research topics of 'Diabetes technology: A primer highlighting the role of the pharmacist'. Together they form a unique fingerprint.

Cite this